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Paying Women For Their Eggs For 
Use In Stem Cell Research 
 
Pamela Foohey 
 
On June 11, 2009, the Empire State Stem Cell Board 
(“Board”), which administers the $600 million in New York 
State funds allotted to stem cell research, voted to allocate a 
portion of those funds to compensate women up to $10,000 for 
“donating” their eggs for use in stem cell research.1  The 
Board‟s decision makes New York the first state to 
affirmatively allow state funds to be used to compensate 
women for providing their eggs for use in stem cell research 
beyond mere reimbursement of associated medical and other 
expenses,2 and, similarly, distinguishes it from most 
 
 Post-Graduate Research Fellow, Harvard Law School; Associate, 
Dorsey & Whitney LLP.  J.D., Harvard Law School, 2008; B.S., New York 
University, Stern School of Business, 2004.  Special thanks to Professor 
Russell Korobkin for helpful input on this Article.  The views expressed in 
this Article are solely those of the author. 
1. Statement of the Empire State Stem Cell Board on the Compensation 
of Oocyte Donors, 
http://stemcell.ny.gov/docs/ESSCB_Statement_on_Compensation_of_Oocyte_
Donors.pdf (last visited Mar. 12, 2010) [hereinafter Statement of Board]; New 
York State Stem Cell Science, Frequently Asked Questions about NYSTEM, 
http://stemcell.ny.gov/nystem_faq.html (last visited Mar. 12, 2010).  Though 
“donation” is not an accurate term as applied to women selling their eggs 
(also called oocytes) for sums greater than the associated medical and other 
expenses, the Board‟s decision and common parlance refer to such selling as a 
donation. 
2. California permits reimbursement for certain expenses.  CAL. HEALTH 
& SAFETY CODE § 125355 (West 2009).  Massachusetts, Connecticut, Indiana, 
and Maryland specifically forbid compensation.  105 MASS. CODE REGS. 
960.006(a) (2009); CONN. GEN. STAT. ANN. § 19a-32d(c)(3) (West 2006 Supp.); 
IND. CODE ANN. § 35-46-5-3 (West 2009); MD. CODE ANN. ECON. DEV. § 10-
439(b) (West 2009).  Louisiana explicitly prohibits the sale of eggs.  LA. REV. 
STAT. ANN. § 9:122 (2009).  Several states ban the sale of all body parts for 
valuable consideration.  See Michelle Bercovici, Biotechnology Beyond the 
Embryo: Science, Ethics, and Responsible Regulation of Egg Donation to 
Protect Women’s Rights, 29 WOMEN‟S RTS L. REP. 193, 204-06 (2008) (listing 
states and noting that these statutes can be read to prohibit the sale of eggs); 
but see Kenneth Baum, Golden Eggs: Towards the Rational Regulation of 
Oocyte Donation, 2001 BYU L. REV. 107, 127 (2001) (arguing that such 
statutes should not be read to cover eggs because “oocytes are, for all 
1
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international countries, which either prohibit payment of any 
amount to women donating their eggs for research purposes or 
limit compensation to reimbursement for certain expenses.3  In 
contrast, the decision aligns New York‟s approach with 
national policy concerning supplying eggs for reproductive 
purposes.4  Indeed, New York permits payment of up to 
$10,000 to women providing their eggs for reproductive 
purposes, and, in the United States, women of certain 
backgrounds and with certain physical characteristics are 
offered, at least initially, as much as $50,000 and $100,000 for 
their eggs.5 
As expected, the Board‟s decision elicited divergent 
reactions.  Proponents focused on the potential advancements 
 
practical purposes, replenishable”).  See also Russell Korobkin, Buying and 
Selling Human Tissues for Stem Cell Research, 49 ARIZ. L. REV. 45, 48 (2007) 
(listing states with statutes that appear to forbid “tissue sales for research 
purposes”). 
3. England allows reimbursement for reasonable out-of-pocket expenses 
with up to an additional 250 pounds for lost earnings.  Likewise, Canada, 
Australia, and Singapore prohibit compensation beyond reasonably-incurred 
expenses.  Bercovici, supra note 2, at 204-06; Debora Spar, Ph.D., The Egg 
Trade: Making Sense of the Market for Human Oocytes, 13 NEW ENG. J. MED. 
1289, 1291 (2007); Baum, supra note 2, at 129.  Sweden, Israel, and South 
Korea forbid reimbursement or compensation in any amount.  Spar, supra, at 
1291; Erika Check, Ethicists and Biologists Ponder the Price of Eggs, 442 
NATURE 606, 606 (2006); Baum, supra note 2, at 129.  Citing the risks of egg 
production and extraction, Japan bans egg donation altogether.  Check, 
supra, at 606. 
4. In the United States, eggs “may be sold at a „fair price‟ for use in 
fertility programs.”  Loane Skene, Recent Developments in Stem Cell 
Research: Social, Ethical and Legal Issues for the Future 22 (Univ. of 
Melbourne, Legal Studies Research Paper No. 385), available at 
http://www.lawgenecentre.org/stemcellfuture.pdf; see also Korobkin, supra 
note 2, at 49 (noting that, “in most states, gametes are actively bought and 
sold for reproductive purposes”).  Most international countries disallow 
payment of any amount or limit compensation to reimbursement, thereby 
aligning their payment policies.  See, e.g., HUMAN FERTILISATION & 
EMBRYOLOGY AUTH., SEED REPORT (2005) (Eng.), available at 
www.hfea.gov.uk/docs/SEEDReport05.pdf; Lori P. Knowles, Canada’s 
Regulatory Oversight of Stem Cell Research, Stem Cell Network (2009), 
available at 
http://www.stemcellnetwork.ca/uploads/File/whitepapers/Canada-Regulatory-
Oversight-of-Stem-Cell-Research.pdf (Can.). 
5. Statement of Board, supra note 1 (describing New York‟s policy as to 
compensation); DEBORA L. SPAR, THE BABY BUSINESS: HOW MONEY, SCIENCE, 
AND POLITICS DRIVE THE COMMERCE OF CONCEPTION 45-46 (2006) (noting that, 
as of 2004, amounts paid for eggs generally ranged from $3,000 to $8,000 per 
donation cycle). 
2http://digitalcommons.pace.edu/plr/vol30/iss3/4
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in stem cell research and the inconsistency between permitting 
payment in the reproductive context and disallowing payment 
in the research context.6  Opponents voiced fears that payment 
might unduly induce women to donate their eggs.7 
Anticipating such opposition, in its written statement, the 
Board opined that “reasonable reimbursement coupled with 
other safeguards protects against [the possibility that women 
may be unduly influenced],” and that “a policy prohibiting 
reasonable payments because they may interfere with a 
woman‟s ability to weigh the risks and benefits of donation is 
unnecessarily paternalistic.”8  The Board further noted that in 
addition to “rigorous review by an institutional oversight 
committee, prohibition against payment of valuable 
consideration, and adherence to [the American Society of 
Reproductive Medicine (“ASRM”)]‟s guidelines,”9 it intended to 
require “full disclosure of all physical and psychological risks 
associated with oocyte donation,” prescribe that “informed 
consent be obtained through a dynamic process focused on the 
donor‟s comprehension of the information provided,” and 
mandate the “availability of psychological counseling prior to 
donation.”10 
Despite the Board‟s assurances, on October 9, 2009, 
Feminists Choosing Life of New York (“FCLNY”),11 a self-
 
6. See Libby Nelson, New York State Allows Payment for Egg Donations 
for Research, N.Y. TIMES, June 26, 2009, at A20; Rob Stein, New York to Pay 
for Eggs for Stem Cell Research, WASH. POST, June 26, 2009, at A04. 
7. See Nelson, supra note 6; Stein, supra note 6. 
8. Statement of Board, supra note 1. 
9. Id.  In regards to supplying eggs for reproduction or research, ASRM 
guidelines provide that paying “sums of $5,000 or more require[s] 
justification and sums above $10,000 are not appropriate.”  Ethics Comm., 
Am. Soc‟y for Reprod. Med., Financial Compensation of Oocyte Donors, 88 
FERTILITY & STERILITY 305, 308 (2007), available at 
http://www.asrm.org/Media/Ethics/financial_incentives.pdf.  As to safeguards, 
ASRM guidelines state that “[c]ompensation should not vary according to the 
planned use of the oocytes . . . , the number or quality of oocytes retrieved . . . 
, the outcome of prior donation cycles, or the donor‟s ethnic or other personal 
characteristics”; that entities compensating women for supplying their eggs 
“should adopt effective information disclosure and counseling processes”; and 
that entities “should ensure equitable and fair provision of [physician] 
services to donors.”  Id. at 308, 305. 
10. Statement of Board, supra note 1. 
11. Feminists Choosing Life of New York, About Us, 
http://www.feministschoosinglife.org/ (last visited Mar. 12, 2010). 
3
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described “pro-life feminist” organization, filed suit in New 
York State court to block the use of state funds to pay women 
who supply their eggs for stem cell research.12  FCLNY argues 
that the compensation program “provides significant monetary 
inducements to women to engage in [a] painful and risky 
procedure, which in part disproportionately appeals to 
economically vulnerable women,” while “fail[ing] to 
satisfactorily provide for informed consent and other 
safeguards to ensure adequate disclosure to women of the risks 
of egg harvesting.”13  In advancing this argument, FCLNY 
identifies an important difference between compensating 
women who provide their eggs for reproductive purposes and 
compensating women who supply their eggs for research 
purposes: for reproductive purposes, younger women with 
particular backgrounds are almost exclusively sought after, 
while for research purposes, researchers can use eggs from a 
diverse set of women.14  This appeal to even younger and older, 
less educated, and poorer women makes compensating women 
for providing eggs to be used in stem cell research precarious: 
women targeted to provide their eggs for research purposes 
may be more likely to agree to do so without clear thought or 
any real choice. 
This Article analyzes the Board‟s decision, first outlining 
the aims of stem cell research, the logistics of egg production, 
and why payment is necessary to obtain a sufficient number of 
eggs for stem cell research purposes; then summarizing the 
arguments regarding compensation; and finally, relying on 
insights from those arguments, focusing on the safeguards the 
 
12. Verified Petition for the Petitioner, Feminists Choosing Life of New 
York v. Empire State Stem Cell Board, No. 8594/2009 (N.Y. Sup. Ct. Oct. 9, 
2009), available at 
http://www.feministschoosinglife.org/files/FCLNY_vs_State_Stem_Cell_Board
_Signed.pdf. 
13. Id. at 9.  For FCLNY‟s additional arguments, see id. at 7-10. 
14. Id. at 9 (“The [compensation program] provides significant monetary 
inducements to women . . . who may not meet the „profile‟ required to receive 
private payments for their eggs to be used for in vitro fertilization 
purposes.”); see also Sarah B. Angel, The Value of the Human Egg: An 
Analysis of Risk and Reward in Stem Cell Research, 22 BERKELEY J. GENDER 
L. & JUST. 183, 197-98 (2007) (noting that “evidence suggests that . . . women 
who have donated for general research purposes are not inclined to 
participate as donors for IVF programs . . . ,” that “researchers only require 
that the oocytes contain healthy cytoplasm,” and that “research donors‟ 
genetic makeup is irrelevant”). 
4http://digitalcommons.pace.edu/plr/vol30/iss3/4
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Board set out in its written statement.  In evaluating the 
decision, this Article concludes that the Board has not crafted 
sufficient safeguards to protect against the possibility that 
women may be unduly influenced to supply their eggs, as it 
sought to do.  Thus, the Article ends by identifying further 
safeguards that the Board should adopt in order to confront the 
full expanse of women‟s potential interactions with its 
compensation program, both as to guarding against undue 
influence and exploitation, and creating a program that 
addresses the continuing needs of the women that New York 
entices with large sums of money to provide their eggs. 
 
I. Stem Cell Research and the Need To Pay For Eggs 
 
Stem cell research has the potential to lead to treatments 
and cures for an array of diseases.  With stem cells, researchers 
can study how cells differentiate, thereby learning the causes of 
various diseases, then use the differentiated cells to test 
medical drugs and treatments, and, hopefully, eventually use 
the stem cells to cure diseases.15  The stem cells required for 
such research and future treatments can come from two 
sources: human embryonic stem cells (“hESCs”) and human 
adult stem cells.16  Though researchers have derived stem cells 
adequate for research from human adult stem cells, some 
researchers argue that the most useful stem cells originate 
from hESCs and, accordingly, that research using hESCs must 
continue.17  HESCs, in turn, come from blastocysts harvested 
approximately five days following fertilization.  The necessary 
blastocysts, in turn, are created in three ways: previously as 
part of in vitro fertilization (“IVF”) treatment and subsequently 
donated to be used for research purposes; specifically for 
research purposes by uniting human egg and sperm; and by 
removing the nucleus of a human egg and replacing it with the 
nucleus of a human body cell, thereby creating a “clonal 
 
15. Russell Korobkin, Autonomy and Informed Consent in 
Nontherapeutic Biomedical Research, 54 UCLA L. REV. 605, 608 (2007). 
16. Id. at 609. 
17. Lisa C. Ikemoto, Eggs as Capital: Human Egg Procurement in the 
Fertility Industry and the Stem Cell Research Enterprise, 34 SIGNS: J. WOMEN 
CULTURE & SOC‟Y 763, 772-73 (2009); Skene, supra note 4, at 3-4.  See also 
infra note 19. 
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embryo.”18 
Of these three methods, the last process holds the most 
promise because it yields a blastocyst with genetic material 
matching the provider of the body cell and, thus, may be used 
to create individually-tailored stem cell therapies.  This 
process, however, requires a fresh human egg, an egg 
necessarily extracted from a woman.19  Moreover, regardless of 
the method used, in the initial stages of research, to create a 
single stem cell line, researchers estimate that they will need 
over two hundred blastocysts; as technology advances, 
researchers most likely still will need over a dozen 
blastocysts.20  Unless researchers use blastocysts discarded 
following IVF treatments and subsequently donated for use in 
stem cell research—of which, given the number of blastocysts 
needed to create one stem cell line, it is unlikely enough will be 
donated to fulfill the needs of researchers—these blastocysts 
will need to be created by using human eggs.  The best and 
only practical source for human eggs at this time is women.21  
Accordingly, in order for stem cell research to proceed, 
thousands upon thousands of eggs must be extracted from 
women. 
Egg production and extraction is a complicated, multi-step 
process that brings with it a long list of restrictions and short-
term and potentially long-term health risks.  In brief, following 
 
18. Korobkin, supra note 15, at 609; Emily Galpern, Beyond Embryo 
Politics: Women’s Health and Dignity in Stem Cell Research, WOMEN‟S 
HEALTH ACTIVIST, May/June 2006, available at 
http://www.geneticsandsociety.org/article.php?id=1999. 
19. Ikemoto, supra note 17, at 773; see also Elizabeth Gerber, Recent 
Development in Health Law: California Limits Egg Donor Compensation in 
Privately-Funded Research, 35 J.L. MED. & ETHICS 220, 221 (2007) (noting 
that though stem cell lines can be created without using human eggs, “the 
use of eggs . . . is the only method thought to have the potential ability to 
create „stem cells that are genetically matched to patients,‟ which may then 
be used to develop replacement organs”). 
20. Ronald M. Green, Five Ethical Questions for SCNT Stem Cell 
Research, 9 MINN. J. L. SCI. & TECH. 131, 137 (2008). 
21. See Lori Gruen, Oocytes For Sale?, 39 METAPHILOSOPHY 285, 287-90 
(2007) (listing the other methods by which eggs may be procured and 
discussing why they are not feasible alternatives); Angel, supra note 14, at 
195-96 (describing alternatives to donated eggs for stem cell research and 
concluding that “because of the dearth of alternative oocyte sources, [stem 
cell research] will be unable to achieve its potential if compensation bans” are 
implemented). 
6http://digitalcommons.pace.edu/plr/vol30/iss3/4
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a battery of ultrasounds and blood tests, a woman providing 
her eggs receives a three-week series of drug injections that 
shut down her ovaries.  After her ovaries shut down, she begins 
a regime of ovarian-hyper-stimulating hormones.  These 
hormones cause between ten and twenty eggs to mature in her 
ovaries.  Following sufficient maturation, a doctor sedates the 
woman with light anesthesia and extracts the mature eggs by 
inserting a needle through the vaginal wall, into the ovary, and 
suctioning out the follicular fluid that contains the eggs.22  
Throughout this process, the woman must follow-up with a 
doctor repeatedly to have her hormone levels checked through 
blood tests and the progress of her ovaries monitored by 
ultrasound.  Also during this process, she may not engage in 
unprotected sex, smoke, drink alcohol, or take drugs, 
prescription or otherwise, without prior permission.23  In total, 
the woman spends approximately fifty-six hours in a “medical 
setting.”24 
At each step of this process, the woman supplying her eggs 
is subject to numerous health risks.  The drugs designed to 
shut down ovarian function suppress a woman‟s natural 
hormone production, which may lead to “hot flashes, difficulty 
with short-term memory, and insomnia.”25  These drugs also 
may cause vaginal dryness, hypertension, formation of blood 
clots, intestinal bleeding, fluid accumulation in the limbs, 
swelling of the limbs, numbness of the limbs, fatigue, 
depression, mood swings, chest pain, bone pain, joint pain, 
muscle pain, migraines, vision problems, dizziness and 
blackouts, nausea, vomiting, diarrhea, anemia, and thyroid 
enlargement.26  Moreover, the FDA has not approved Lupron, 
the drug most often prescribed to shut down ovaries, for such 
 
22. Bercovici, supra note 2, at 194-95. 
23. Kimberly D. Krawiec, Altruism and Intermediation in the Market for 
Babies, 66 WASH. & LEE L. REV. 203, 220-21 (2009). 
24. Angel, supra note 14, at 203. 
25. Bercovici, supra note 2, at 195. 
26. Gerber, supra note 19, at 221; Galpern, supra note 18, at 2; Human 
Cloning and Embryonic Stem Cell Research After Seoul: Examination 
Exploitation, Fraud, and Ethical Problems in the Research: Hearing Before 
the Subcomm. on Criminal Justice, Drug Policy, and Human Resources of the 
H. Comm. on Government Reform, 109th Cong. 79 (2006) (statement of Judy 
Norsigian, Executive Director, Our Bodies Ourselves) [hereinafter Norsigian 
Statement], available at http://frwebgate.access.gpo.gov/cgi-
bin/getdoc.cgi?dbname=109_househearings &docid=f:29580.pdf. 
7
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use.  Although Lupron‟s “off-label” use is allowed, and despite 
the fact that since 2006 the FDA has received more than 6,000 
complaints regarding the drug, including twenty-five deaths 
related to “off-label” use, little research exists about the exact 
short and long-term effects of its use in connection with egg 
extraction.27 
The drugs that hyper-stimulate the ovaries may cause 
even more serious side effects.  In addition to the relatively 
minor short-term side effects of mood swings, water retention, 
general abdominal discomfort, and ovarian swelling and cysts, 
hyperstimulation of ovaries can cause ovarian 
hyperstimulation syndrome (“OHSS”), which can result in 
dehydration, nausea and vomiting, kidney problems and 
failure, liver problems, fluid retention in the lungs, blood clots, 
the formation of cysts in the ovaries, and shock.28  In rare 
instances, OHSS becomes life-threatening and requires the 
removal of the affected ovary or ovaries, and “can lead to stroke 
and „arterial occlusion with loss of limb or death.‟”29  Overall, 
“physicians report that even moderately severe OHSS can be a 
„devastating, frightening experience for a donor.‟”30 
Twenty to thirty-three percent of women undergoing the 
egg extraction process report the less severe short-term side 
effects.31  OHSS affects about six percent of women.32  The 
 
27. Galpern, supra note 18, at 2; Diane Beeson & Abby Lippman, Egg 
Harvesting for Stem Cell Research: Medical Risks and Ethical Problems, 13 
REPROD. BIOMEDICINE ONLINE 573, 575 (2006). 
28. Krawiec, supra note 23, at 221; Bercovici, supra note 2, at 195; 
Galpern, supra note 18, at 2; Norsigian Statement, supra note 26. 
29. Norsigian Statement, supra note 26, at 81 (referencing memorandum 
of Dr. Suzanne Parisian).  See also Krawiec, supra note 23, at 221; Galpern, 
supra note 18, at 2; John Reichard, Stem Cell Bill Foes Warn of Egg Donation 
Risks, CQ HEALTHBEAT NEWS, Apr. 10, 2007, available at 
http://public.cq.com/docs/hb/hbnews110-000002487888.html (reporting that, 
at a United States Senate briefing, “Jennifer Lahl of the Center for Bioethics 
and Culture Network, described 34 cases of arterial thrombosis she said have 
resulted from assisted reproductive technologies entailing ovarian 
stimulation.  Fifteen of the cases involved strokes, three involved heart 
attacks, and two cases were fatal”). 
30. Angel, supra note 14, at 203. 
31. Galpern, supra note 18, at 2. 
32. Gerber, supra note 19, at 221.  Some experts contend that 
implementation of prevention strategies can reduce the risk of OSHH, such 
as identifying women who are especially at risk of developing OSHH.  Angel, 
supra note 14, at 204-05.  “[Y]oung age, ovary abnormalities, low body 
weight, a history of allergies, and underlying thrombophia,” as well as 
8http://digitalcommons.pace.edu/plr/vol30/iss3/4
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more serious short-term side effects of the drugs, including 
those associated with OHHS, affect between 0.1 and eight 
percent of women supplying their eggs.33  For example, 1.4 in 
every 1,000 women undergoing ovarian hyperstimulation 
experience kidney failure,34 and, as of 2005, five women in the 
United Kingdom have died of complications related to OHSS.35 
Additionally, the process used to remove the mature eggs 
may cause bleeding and infection.  During the extraction, the 
bowel, bladder, and nearby blood vessels may be punctured, 
resulting in internal bleeding that may require major 
abdominal surgery.36  Finally, sedation by anesthesia carries 
risks of its own.37 
The long-term health risks of shutting-down a woman‟s 
ovaries and then hyperstimulating them to produce numerous 
eggs remain unknown and generally unstudied.  Some small, 
limited studies posit a link between breast, ovarian, and 
uterine cancer and the drugs used to suppress ovarian function 
and hyper-stimulate the ovaries.38  Anecdotal stories of women 
who have undergone the production and extraction procedure 
later developing colon cancer at extremely young ages similarly 
identify a potential link between egg donation and colon 
cancer.39  Studies also link the drugs with future infertility.40 
When faced with all these restrictions and potential side 
 
“irregular menstrual cycles or poly-cystic ovaries” may increase the risk of 
developing OSHH.  Id. 
33. Galpern, supra note 18, at 2. 
34. Bercovici, supra note 2, at 195. 
35. Beeson & Lippman, supra note 27, at 575. 
36. Krawiec, supra note 23, at 221. 
37. Angel, supra note 14, at 209 (“Mortality risk associated with 
anesthesia are low and amount to less than one per 300,000.”). 
38. Id. at 207-09; Gerber, supra note 19, at 221.  One study found that 
women who were given a certain ovarian hyperstimulation drug “had 11 
times the risk of developing ovarian tumours compared with the general 
population.”  Helen Pearson, Health Effects of Egg Donation May Take 
Decades To Emerge, 442 NATURE 607, 607 (2006). 
39. See It’s Time for an Egg Donor Registry and Long-term Follow-up, 
110th Cong. (2007) (testimony of Jennifer Schneider, M.D.). 
40. Angel, supra note 14, at 205-07; Bercovici, supra note 2, at 195; 
Gerber, supra note 19, at 221.  For a detailed analysis of the known and 
potential risks of egg donation, see Institute of Medicine & National Research 
Council, Workshop Report, Assessing the Medical Risks of Human Oocyte 
Donation for Stem Cell Research, available at 
http://www.nap.edu/openbook.php?isbn=030910355X. 
9
2010] PAYING WOMEN FOR THEIR EGGS 909 
effects, it is understandable why payment may be necessary.  
The experiences of the several states that provide funds for 
stem cell research demonstrate that compensation is essential 
in order for researchers to obtain the eggs necessary for stem 
cell research to proceed.  Though these states provide funding 
for stem cell research, they prohibit compensation beyond mere 
reimbursement for associated medical and other expenses to 
women supplying their eggs for that research.41  Consequently, 
stem cell research largely remains at a standstill because 
researchers do not have enough human eggs.42  For example, 
though the Harvard Stem Cell Institute spent $100,000 over a 
period of a year and a half on advertising to recruit egg donors, 
during that time, it did not find a single woman willing to 
donate her eggs.  The director of the Institute explained: “We‟ve 
had hundreds of calls from women who are interested in 
donating, but when they find out about the time, effort, and 
pain involved, they simply can‟t take the time to go forward.”43 
Given that stem cell research using hESCs will continue, 
and that it is questionable whether enough blastocysts 
discarded following IVF treatments will be donated to stem cell 
research for such research to advance without creating 
additional blastocysts, this need to pay women for supplying 
their eggs for stem cell research to proceed creates a dilemma: 
the process of egg extraction is so time-consuming and painful 
and comes with so many risks that in order for researchers to 
have a sufficient number of eggs, payment seems necessary, 
but the process is so time-consuming and painful and comes 
with so many risks that the amount of payment necessary to 
persuade women to provide their eggs has the potential to 
create situations in which women are unduly induced or 
exploited44 into supplying their eggs or agreeing to the process 
 
41. See supra note 2 and accompanying text. 
42. Emily Singer, Human Therapeutic Cloning at a Standstill: A Lack of 
Human Eggs Has Created a Major Roadblock in One of the Most Promising 
Areas of Stem-Cell Research, TECH. REV., Oct. 9, 2007, available at 
http://www.technologyreview.com/Biotech/19488/. 
43. Id. 
44. If an inducement is undue, “the inducement . . . impairs, not just 
influences, judgment, so that „the offered good leads to poor judgment which 
makes [a person] take unnecessary, unreasonable, and excessive risks of 
harm,‟” or the inducement is coercive.  Gruen, supra note 21, at 295, 297.  
Coercion is “an extreme form of influence by another person that completely 
controls a person‟s decision.”  J.P. Bentley & P.G. Thacker, The Influence of 
10http://digitalcommons.pace.edu/plr/vol30/iss3/4
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without sufficient understanding of the risks involved.  It is 
this dilemma that opponents and proponents of compensation 
primarily have discussed since the emergence of stem cell 
research and that the Board confronted when it outlined its 
compensation policy. 
 
II. Arguments Regarding Compensation 
 
In order to evaluate the Board‟s safeguards, it is important 
to understand the arguments of opponents and proponents of 
compensation, which the Board attempted to balance when it 
crafted its decision.  This section summarizes those arguments; 
unless otherwise indicated, this section recounts the opinions of 
commentators and not my own.  The main arguments 
regarding compensating women who provide their eggs for 
stem cell research divide into two categories: (a) arguments 
about undue inducement and exploitation, and (b) arguments 
about commodification. 
 
A. Undue Inducement and Exploitation 
 
First, analogizing to live organ donation, opponents of 
compensation argue that the underlying risks of egg production 
and extraction are so serious and unknown that allowing 
compensation would create an undue incentive to submit to a 
high-risk procedure without a concomitant personal benefit 
beyond the payment.45  In the context of most medical research, 
donors anticipate receiving a direct medical benefit from their 
donation within their lifetime, either for themselves or for a 
loved one.  Likewise, when women provide their eggs for 
reproductive purposes, they may receive a discount on the cost 
of their reproductive therapies from which they hope to receive 
 
Risk and Monetary Payment on the Research Participation Decision Making 
Process, 30 J. MED. ETHICS 293, 293 (2004).  In contrast, and acknowledging 
that “[t]he concept of exploitation, its meaning, and its appropriate 
application” are debated heavily, as a “minimal understanding,” essentially, 
“an individual exploits another individual if one of them has something the 
other needs and stands in a powerful relationship over the latter, and uses 
that relationship and the fact that he or she has something the subordinate 
needs, to take unfair advantage of the less powerful individual.”  Gruen, 
supra note 21, at 293. 
45. Gerber, supra note 19, at 221. 
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a direct medical benefit or they may benefit in knowing that a 
child may be born from their provision, possibly to someone 
they know.  In contrast, stem cell research is far from 
producing any analogous benefit: at this point, researchers will 
use eggs for research only and not for stem cell therapies.46  
Considering this lack of direct benefit beyond the payment, 
opponents fear that conflicts of interest will cause researchers 
to misrepresent the risks of egg extraction or neglect to obtain 
informed consent, or that the norms of the doctor-patient 
relationship, in which the patient‟s care is the doctor‟s primary 
concern, will be violated such that doctors discount or do not 
attend to the health of women supplying their eggs.47 
Opponents of compensation further argue that only by 
prohibiting payment and other “inducements” will women truly 
be able to consent to the egg extraction procedure.48  Opponents 
cite the experience of women with a research lab in South 
Korea.  In 2004, Dr. Hwang Woo Suk became the first person to 
successfully clone a human embryo and extract a stem cell line 
from that cloned embryo.  Shortly before the announcement, 
reporters discovered that Dr. Hwang had either paid women in 
violation of South Korea‟s ban on compensation or recruited 
women directly from his lab to donate the eggs he used to 
create the stem cell line.49  Opponents contend that Dr. Hwang 
compelled these women to give their eggs with money and 
promises of continued employment.50  Similarly, in the wake of 
the recent financial crisis, fertility clinics in the United States 
reported a surge in women inquiring about egg donation for 
reproductive purposes.  In some instances, women‟s husbands 
 
46. David Magnus & Mildred K. Cho, Issues in Oocyte Donation for Stem 
Cell Research, SCIENCE, June 17, 2005. 
47. See, e.g., Beeson & Lippman, supra note 27, at 575-77 (discussing 
potential conflicts of interest); Judith F. Daar, Regulating the Fiction of 
Informed Consent in ART Medicine, 1 AM. J. OF BIOETHICS 19, 19-20 
(questioning “whether informed consent can ever be a practical reality in a 
field of medicine grounded in the trilogy of rapidly advancing technologies, 
emotionally charged expectations, and commercialism”). 
48. See Radhika Rao, California’s Stem Cell Initiative: Converting the 
Legal and Policy Challenges: Coercion, Commercialization, and 
Commodification: The Ethics of Compensation for Egg Donors in Stem Cell 
Research, 21 BERKELEY TECH. L.J. 1055, 1058-59 (2006). 
49. Id. at 1059-60; see also Korobkin, supra note 2, at 53. 
50. Rao, supra note 48, at 1059-60. 
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called the clinics themselves, “offering up their wives.”51  These 
examples highlight concerns regarding women being pressured 
or exploited into supplying their eggs, and lead opponents of 
compensation to call for the protection of women who may 
agree to provide their eggs when presented with payment when 
they otherwise would not, especially considering that a portion 
of these women may be less economically advantaged than 
women providing their eggs for reproductive purposes and, 
thereby, may be enticed to the point of undue inducement by 
monetary incentives.52 
In response, proponents of compensation assert that the 
substantial risks associated with, and the rigors of, egg 
extraction constitute the very reasons to permit payment: it is 
only fair that women receive compensation.53  Also, if women 
do not receive compensation, every individual and entity 
involved in stem cell research but the woman providing her 
eggs benefits monetarily or in some other way.54  According to 
proponents, it is precisely because a woman supplying her eggs 
may not see a personal benefit from stem cell research that 
payment is necessary. 
Additionally, proponents of compensation emphasize that 
such non-payment may reinforce the perception that women 
should be willing altruistically to undergo a lengthy, painful, 
and risky procedure in order to advance the health and well-
being of others, especially when that contribution is necessarily 
intertwined with reproduction.  Particularly considering that 
the standard practice is to allow compensation to medical 
research subjects,55 proponents worry this non-payment 
scheme may entrench the notion that two of women‟s primary 
functions are reproduction and care-giving, particularly when 
those two align.56  Simultaneously, when compared with the 
acceptability of paying women to provide their eggs for 
 
51. Melinda Beck, Ova Time: Women Line Up To Donate Eggs – for 
Money, WALL ST. J., Dec. 9, 2008, at D1. 
52. Angel, supra note 14, at 214-15 (noting that “[o]ne written opinion in 
the report by President Bush‟s Commission on Bioethics states that 
„financially vulnerable populations‟ will be disproportionately represented 
among oocyte donors for research”); Rao, supra note 48, at 1059-60. 
53. Gerber, supra note 19, at 221. 
54. Korobkin, supra note 2, at 46. 
55. Angel, supra note 14, at 200. 
56. Rao, supra note 48, at 1061-63. 
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reproductive purposes, proponents also worry that a ban on 
compensation to women supplying their eggs for research 
purposes may elevate the importance of women serving as 
reproduction vehicles: such a ban may signal that paying 
women for their eggs for reproductive purposes is only fair 
because women, first and foremost, are innately made for 
reproduction and only that work deserves value.57  In short, 
proponents contend that if payment is acceptable in the 
reproduction context, it should be acceptable in the research 
context because the procedures undergone by women providing 
eggs for either purpose are the same.58 
As to the assertion that only the removal of monetary 
incentives will permit women to truly consent to supplying 
their eggs, proponents of compensation note that this argument 
extends too far.  Though compensation may factor, perhaps 
heavily, into a woman‟s decision to supply her eggs or may 
cause a woman‟s husband to offer her up, the fraud in South 
Korea demonstrates that payment is not the only catalyst for 
forcing women to provide their eggs.  Even when compensation 
is disallowed, proponents observe that women may experience 
intense pressure and find themselves in situations ripe for 
exploitation.59 
Therefore, proponents stress that it is more important to 
provide women with adequate information about the egg 
extraction procedure so that they can make informed choices 
than to dissuade them from undergoing a risky procedure 
based on a theory smacking of paternalistic protection that 
 
57. Bercovici, supra note 2, at 209 (“Regulations on compensation thus 
must apply equally to egg donation for IVF and research, sending a message 
that female work is valued equally, whether it be for reproductive or research 
purposes.”); Green, supra note 20, at 139 (“The view that women can be paid 
for eggs for reproductive but not research purposes may reflect the belief that 
maternally related sacrifices are somehow proper to women, whereas a 
commitment to science research is not.”). 
58. Rao, supra note 48, at 1065. 
59. Bentley & Thacker, supra note 44.  This study found that although 
monetary payment may increase willingness to participate in medical 
research, such payments do not “blind respondents to risk.”  The study notes, 
however, that what constitutes undue influence based on monetary 
incentives differs from one individual to another: “It is not the dollar amount 
alone that determines what is undue inducement; the impoverishment of 
subjects and the risk of injury from the study are also considerations.”  Id.  
This insight is addressed in Part III. 
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only when women are not distracted by money or other 
inducements can they make a choice about that procedure.60  
Permitting compensation and establishing a structure under 
which women can truly decide whether to supply their eggs 
after being presented with all the relevant information may 
guard against the type of exploitation experienced in South 
Korea: egg donation will transform from a mysterious 
procedure, the full logistics mostly unknown by the relevant 
population,61 deemed something that should be agreed to 
through solely altruistic motivations, into a procedure openly 
discussed and accompanied by general practices like other 
medical research.62  Hence, according to proponents, the key to 
protecting women is ensuring: (1) that they are fully informed 
about the risks of egg extraction, including the uncertainty of 
risk; (2) that potential conflicts of interests are minimized; (3) 
that the circumstances of each woman contemplating donation 
are considered to determine whether monetary or other 
incentives are unduly inducing her to supply her eggs; (4) that 
research regarding the risks is bolstered; and (5) that women 
are assured medical treatment during and after the egg 
extraction process.63 
 
 
60. See Korobkin, supra note 2, at 52 (“[T]he suggestion that donors are 
not able to make a voluntary decision when money is at issue takes on the 
added connotation of gender stereotype and discrimination.”). 
61. See supra note 43 and accompanying text (demonstrating that, 
overall, women do not know the logistics of egg extraction).  See also 
Reichard, supra note 29 (reporting on a Romanian woman who agreed to sell 
her eggs in order to raise money for her wedding, who then spent fourteen 
days in intensive care because of complications with the extraction process, 
but who refused to tell her doctors that she had undergone egg extraction 
seemingly because she viewed admitting she had sold her eggs as shameful). 
62. See Rao, supra note 48, at 1065-66 (noting that by “denying [women] 
any right to receive compensation or otherwise share in the profits [of stem 
cell research], . . . the rubric of privacy [is invoked]. . . . The problem is that 
privacy . . . provides no power to control the body part . . . .”). 
63. See, e.g., Bentley & Thacker, supra note 44 (commenting on the 
variability of undue inducement); John A. Robertson, Assisting Reproduction, 
Choosing Genes, and the Scope of Reproductive Freedom, 76 GEO. WASH. L. 
REV. 1490, 1504 (2008) (proposing “greater attention to informed consent, 
clinical practice, and coverage of medical care in the case of injury”); Spar, 
supra note 3, at 1290 (discussing the need for research). 
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B. Commodification 
 
Second, opponents of compensation declare that permitting 
payment will lead to the commodification of women and of 
human life.  In the context of egg donation for reproductive 
purposes and surrogacy, some feminists argue that “in this 
nonideal world of ours, treating women like anonymous 
fungible breeders objectifies them and recreates 
subordination.”64  Likewise, opponents claim that 
compensating women for supplying their eggs for stem cell 
research objectifies them by “translat[ing] women‟s bodies and 
their physiological processes into a product,” thereby turning 
women and their reproductive material into chattel, 
diminishing the value of the individual generally, and violating 
conceptions of personhood.65  Paying a woman for her eggs also 
amounts to paying for a bodily intrusion, which similarly 
undermines personhood.66  Further, opponents assert that 
combining payment with donation for research purposes might 
create a caste system: minority women, poorer women, and 
women without academic or athletic achievements will become 
the suppliers of eggs for research while white women, 
economically-advantaged women, and accomplished women 
(according to societal norms) will continue to provide eggs for 
reproductive purposes.67 
Proponents of compensation rebut that selling eggs, 
especially for use in stem cell research, does not objectify 
women nor does it violate conceptions of individuality and 
personhood.68  Rather, proponents declare that restricting 
women‟s choices through prohibiting payment serves to 
infantilize women, constricting their autonomy, depriving them 
 
64. MARGARET JANE RADIN, CONTESTED COMMODITIES: THE TROUBLE WITH 
TRADE IN SEX, CHILDREN, BODY PARTS AND OTHER THINGS 149 (1996). 
65. Angel, supra note 14, at 213-14. 
66. Id. at 214; see also Lynn M. Squillace, Too Much Of A Good Thing: 
Toward A Regulated Market In Human Eggs, 1 J. HEALTH & BIOMEDICAL L. 
135, 143 (2005) (“Egg donation has also been viewed as the ultimate form of 
patriarchy, where male doctors and egg brokers encourage healthy, fertile 
female donors to undergo invasive procedures . . . at unknown risk to the 
donor.”). 
67. Angel, supra note 14, at 215. 
68. See, e.g., RUSSELL KOROBKIN, STEM CELL CENTURY 193 (2007) 
(“[S]elling a cycle of eggs does not, in itself, interfere with the ability of the 
seller to fulfill an essential element of personhood . . . .”). 
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of an aspect of reproductive control, denying them a source of 
power and liberation, enforcing paternalism, and entrenching 
inequality.69  Proponents of compensation emphasize that 
women should be allowed to make their own decisions with 
respect to the appropriate uses of their bodies, provided that 
they are fully informed of the risks of those decisions. 
Further, though receiving compensation for bodily 
intrusion might undermine personhood, proponents note that 
payment for providing eggs for reproductive purposes has 
proceeded for many years without noticeably damaging the 
dignity of women.  Indeed, as viewed by proponents, the sale of 
eggs for reproductive purposes seems more troubling than the 
sale of eggs for research purposes: for reproduction, women 
with certain attributes are preferred, which implies that 
certain women are worth more than other women.  Contrary to 
fears about creating a caste system, permitting compensation 
in both contexts may mitigate this implication: other than 
genetic diversity, researchers do not prefer particular 
attributes.70  Additionally, returning to discord between 
permitting payment for supplying eggs in the reproductive 
context and disallowing payment in the research context, 
proponents of compensation assert that even if extracting eggs 
from women may lead to their commodification and the 
entrenchment of their subordination, payment alone will not 
produce this outcome: this consequence is just as likely if 
altruistic donation is permitted.71 
Separate from arguments regarding the commodification of 
women, opponents of compensation argue that embryos are 
equivalent to persons, and, thus, selling embryos and their 
component parts—including eggs—disrespects human life.72  In 
response, proponents note that this argument is made with the 
ultimate goal of preventing stem cell research based on views 
about human life and has nothing to do with a concern for 
women.  Accordingly, proponents contend that this argument 
relates to the debate about the propriety of stem cell research, 
 
69. Angel, supra note 14, at 216 (“Many commentators find that the 
entire argument against the commodification of oocyte donation . . . devalues 
women as autonomous equals.”); Squillace, supra note 66, at 143. 
70. KOROBKIN, supra note 68, at 194-95; Gruen, supra note 22, at 301-03. 
71. KOROBKIN, supra note 68, at 195. 
72. Bercovici, supra note 2, at 208. 
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not the question of compensating women who provide their 
eggs for such research once it is decided that the research 
should proceed.73 
 
C. Other Concerns 
 
Though not raised by opponents or proponents of 
compensation, as New York is the only state that permits 
compensation for providing eggs for use in stem cell research, 
concerns about creating a new form of “reproductive tourism” 
are warranted.  In the context of other reproductive technology, 
instances of women traveling to jurisdictions that permit 
compensation are well-documented.74  Similarly, allowing 
compensation may attract women from other states and 
countries to New York.  Taking as given that women will 
supply their eggs for both reproductive and research purposes, 
I argue that the best solution is to recognize the potential 
problem and enact safeguards to ensure that all women 
contemplating supplying their eggs, including those traveling 
from other jurisdictions, are able to make free and informed 
choices. 
Indeed, taking as given payment to women providing their 
eggs for reproductive purposes and the acceptability of 
altruistic donation for both reproductive and research 
purposes, I find the arguments for permitting payment for 
research purposes persuasive: not permitting compensation 
may elevate the importance of women as reproductive vehicles 
and entrench notions about women‟s natural altruism in the 
areas of reproduction and care-giving.  In an imperfect society 
where women are exploited and subordinated such that 
compensation becomes a concern as to their continued 
 
73. Id. at 208-09; Rao, supra note 48, at 1065. 
74. See, e.g., Beeson & Lippman, supra note 27, at 577 (relating the story 
of “impoverished, semi-literate young Romanian factory workers . . . 
repeatedly sell[ing] their eggs for US $250 to make up for the absence of 
employment opportunities that provide a living wage”); June Carbone & 
Paige Gottheim, Markets, Subsidies, Regulation, and Trust: Building Ethical 
Understandings Into the Market for Fertility Services, 9 J. GENDER RACE & 
JUST. 509 (2006) (discussing reproductive tourism); Lisa C. Ikemoto, 
Reproductive Tourism: Equality Concerns in the Global Market for Fertility 
Services, 27 LAW & INEQUALITY: J. THEORY & PRAC. 277 (2009) (also discussing 
reproductive tourism). 
18http://digitalcommons.pace.edu/plr/vol30/iss3/4
918 PACE LAW REVIEW [Vol. 30:3 
exploitation and the entrenchment of their subordination, the 
Board‟s solution of paying women who supply their eggs to 
stem cell research may be the better alternative: it is the 
alternative which takes into account the reality that women 
already are supplying their eggs in an atmosphere of 
incomplete information and potential coercion,75 and which 
posits that providing women with full information and the 
ability to make their own decisions, including as to accepting 
payment, will enhance their autonomy. 
Nevertheless, perhaps the more pertinent question is 
whether eggs should be harvested from women for any purpose 
at this time: the process of egg extraction is so risky and 
unstudied that subjecting women to it may be improper until 
more research is completed.  Historically, untested hormones, 
including diethylstilbestrol and hormone replacement therapy, 
have been used to abuse women‟s reproductive functions.76  
Considering this and other historical subordination of women 
by the sciences,77 a temporary prohibition against the 
extraction of eggs from women who do not need to undergo the 
procedure to have children themselves, such as for IVF, may be 
warranted.  Only after comprehensive research is conducted 
and women can truly consider what undergoing egg extraction 
may mean for them and women‟s status generally should the 
question of the propriety of subjecting women to egg extraction 
be re-apprised. 
 
III. Bolstering the Board‟s Decision 
 
Having decided to pay women who supply their eggs for 
stem cell research, the Board appropriately recognized the 
potential for the undue influence and exploitation of these 
women.78  In recognizing this possibility, the Board outlined 
safeguards that begin to incorporate some of the insights 
 
75. See supra notes 49-51 and 61, and accompanying text. 
76. Beeson & Lippman, supra note 27, at 575. 
77. See, e.g., DONNA J. HARAWAY, SIMIANS, CYBORGS, AND WOMEN 8 (1991) 
(“The degree to which the principle of domination is deeply embedded in our 
natural sciences . . . must not be underestimated. . . . Women know very well 
that knowledge from the natural sciences has been used in the interests of 
our domination and not our liberation.”). 
78. See supra note 8 and accompanying text. 
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advanced by both opponents and proponents of compensation 
as to what may lead to or evidence undue influence and 
exploitation.  Roughly, the Board has pledged: to pay women 
who supply their eggs “reasonably” and an amount less than 
“valuable consideration”; not to vary the amount of 
compensation based on the outcome of the egg extraction 
process, the characteristics of the woman supplying her eggs, 
or that woman‟s prior history of producing eggs; to disclose all 
of the risks, including psychological risks, associated with egg 
extraction; to obtain informed consent by following a “dynamic 
process” including counseling; to provide doctors‟ services to the 
women supplying their eggs; and, finally, to implement 
“rigorous review by an institutional oversight committee.”79 
Though the Board‟s safeguards begin to address some 
dangers of women‟s potential interactions with its 
compensation program, overall, the above statements read 
rather murky and malleable.  What constitutes “valuable 
consideration”?  How will the “dynamic process” of informed 
consent proceed?  To what extent will doctors‟ services be 
provided?  What constitutes “rigorous review” by the 
institutional oversight committee?  Also, all of the Board‟s 
safeguards address concerns raised with regard to women 
providing their eggs for reproductive purposes.80  The Board‟s 
compensation program, however, may appeal to a diverse group 
of women.  Will (and how will) the institutional oversight 
committee‟s “rigorous review” address the potential differences, 
on average, between women who supply eggs for reproductive 
purposes and women who supply eggs for research purposes?  
Further, given the unknown long-term risks of egg production 
and extraction, does (and how does) the Board intend to 
address the potential continuing needs of the women it 
encourages to undergo a risky medical procedure?  The Board 
can strengthen its decision by clarifying these and similar 
questions. 
Perhaps most critical to ensuring the well-being of the 
entire universe of women who supply their eggs, the Board 
 
79. Statement of Board, supra note 1. 
80. See generally Ethics Comm., Am. Soc‟y for Reprod. Med., supra note 
9 (outlining safeguards aimed at women providing their eggs for reproductive 
purposes).  Similarly, all of the Board‟s safeguards should apply equally to 
women supplying their eggs for reproductive purposes. 
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should clarify “valuable consideration” beyond paying a woman 
less than $10,000 per egg extraction procedure.  What 
constitutes valuable consideration such that the compensation 
creates undue inducement will vary based on the 
circumstances of the woman supplying her eggs.81  A college or 
graduate student82 who intends to use the money to pay 
student loans may conceptualize $10,000 much differently than 
a woman who intends to use the money to feed her children or 
pay for housing.  Likewise, a woman who earns around 
minimum wage, about $15,000 per year,83 and who anticipates 
few future increases in income, will view $10,000 much 
differently than a college-educated woman in her twenties or 
early-thirties who foresees a lifetime of career advancement.  
In the context of surrogacy, for which women are paid on 
average about $10,000 and which similarly raises concerns 
about class and race-based exploitation,84 some surrogacy 
agencies and contracts prescribe that the woman 
contemplating acting as a surrogate must make a minimum 
income or be above a certain wealth line in order to become a 
surrogate.85  The Board should implement a similar rule.  This 
rule will distinguish those women whose financial situations 
create a substantial likelihood that being compensated 
thousands and thousands of dollars to provide their eggs will 
lead them to discount the risks of egg extraction so greatly that 
they cannot be said to have made a real choice.86  Though not 
all women falling below the minimum income or wealth line 
 
81. See supra note 59 and accompanying text. 
82. See, e.g., Angel, supra note 14, at 198 (discussing the characteristics 
of women sought to provide eggs for reproductive purposes). 
83. Effective July 24, 2009, the federal minimum wage is $7.25 per hour.  
Fair Labor Standards Act, 29 U.S.C. § 206(a)(1)(C) (2006). 
84. CATHARINE A. MACKINNON, SEX EQUALITY 1193-94, 1205 (2d ed. 
2007). 
85. See LORI ANDREWS, BETWEEN STRANGERS 64-65 (1989); Mark 
Strasser, Parental Rights Terminations: On Surrogate Reasons and 
Surrogacy Policies, 60 TENN. L. REV. 135, 215 (1992).  Special thanks to 
Professor Catharine MacKinnon for noting this parallel. 
86. See Gruen, supra note 21, at 303 (positing that if $5,000-$15,000 was 
“routinely offered to women of color in exchange for oocytes, it is much more 
likely that significant problems with exploitation and undue influence would 
surface”).  These women also may withhold important medical information, 
the disclosure of which would prohibit them from undergoing the egg 
extraction procedure.  See HUMAN FERTILISATION & EMBRYOLOGY AUTH., supra 
note 4, at 13. 
21
2010] PAYING WOMEN FOR THEIR EGGS 921 
will discount the risks of egg extraction so severely, such a rule 
will serve as a proxy for the undue influence against which the 
Board has pledged to protect.  Moreover, given that the egg 
extraction procedure is risky and understudied and that the 
women providing their eggs to stem cell research are unlikely 
to see a direct medical benefit—and thereby can be posited to 
be providing their eggs solely for the advancement of science, 
or, more likely, the money87—potentially precluding some 
women who are not being unduly influenced from supplying 
their eggs in exchange for preventing other women from 
agreeing to egg extraction without making a real choice seems 
a reasonable tradeoff, at least until the risks of egg extraction 
are better understood.88 
In addition, as to informed consent and the disclosure of 
the risks associated with egg extraction, studies demonstrate 
that how egg “donation” is presented to women upon first 
contact impacts their ongoing perceptions of the risks of the egg 
extraction procedure.89  Thus, it is important that when a 
woman initially contacts an entity affiliated with New York‟s 
compensation program, she be given an accurate description of 
the egg extraction procedure and all the possible associated 
risks prior to a discussion of compensation.  Medically-trained 
personnel should take the initial call so that any questions 
about the procedure and the risks are answered immediately.  
Following this call, the woman should receive a standardized 
written information pamphlet, which will allow her to 
contemplate its contents before she meets anyone in-person: 
first hearing about the procedure and its risks in-person may 
 
87. See supra notes 42 & 43, and accompanying text. 
88. Such concerns are especially poignant given that egg production and 
extraction necessarily involve an invasive medical procedure that shuts down 
and then stimulates a woman‟s reproductive functions.  See supra notes 25-
27, and accompanying text. 
89. See, e.g., Carson Strong, How Should IVF Programs Handle Initial 
Disclosure of Information to Prospective Ovum Donors?, 1 AM. J. OF BIOETHICS 
23, 23-24 (2001) (discussing the results of a “study evaluating the 
thoroughness with which infertility programs provide information about the 
risks of ovum donation when first contacted by prospective donors”); Gregory 
Stock, Eggs For Sale: How Much is Too Much?, 1 AM. J. OF BIOETHICS 26, 26 
(2001) (noting that the same study “suggest[s] that many egg-donation 
agencies offer limited, perhaps ever disingenuous risk information during 
preliminary phone calls from prospective egg donors” and that this “might 
influence some of these potential donors to behave differently had they gotten 
more detailed risk information up front”). 
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pressure the woman into agreeing to the procedure.90  This 
pamphlet should summarize, clearly and honestly, the risks of 
egg production and extraction, including the fact that the risks 
are generally unknown and unstudied, using plain language, 
such as stating that women can and have died from OHSS 
rather than vaguely noting that OHSS can be “life-
threatening.”  In connection with egg donation for reproductive 
purposes, the New York State Department of Health provides a 
guidebook for women contemplating egg donation entitled 
Thinking of Becoming an Egg Donor?91  The Board can tailor 
this pamphlet for stem cell research, perhaps changing the 
wording so “supply” or “provide” eggs replace the inapt “donor” 
and “donation.” 
Once a woman meets in-person about supplying her eggs, 
three counseling sessions should be required as part of the 
“dynamic process” of informed consent: one with a doctor to 
discuss the medical procedure and its risks; another with a 
psychologist to discuss the potential psychological effects of egg 
extraction, including the psychological effects of providing eggs 
to stem cell research, for which the woman will receive no 
direct benefit and for which the woman‟s eggs may be used in 
unforeseeable ways;92 and a third with a patient advocate to 
discuss the woman‟s decision-making process to supply her 
eggs.  This patient advocate should engage the woman in a 
conversation about why and how she decided to supply her 
eggs, discussing with the woman whether she appreciates all 
the consequences of her decision and whether she is 
discounting the risks of the procedure because of financial or 
other concerns,93 thereby potentially eliciting information 
about the woman being unduly influenced into providing her 
eggs.  For example, this conversation may uncover that the 
woman‟s husband is demanding she supply her eggs and that 
 
90. See Strong, supra note 89, at 24-25 (additionally noting that an in-
person meeting involves a time commitment that may make a woman more 
likely to agree to the procedure). 
91. N.Y. STATE TASK FORCE ON LIFE & THE LAW, THINKING OF BECOMING 
AN EGG DONOR?, available at 
http://www.health.state.ny.us/publications/1127.pdf. 
92. See Ikemoto, supra note 17, at 775. 
93. See Ethics Comm., Am. Soc‟y for Reprod. Med., supra note 9, at 307 
(suggesting similar). 
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she would not do so but for the pressure.94  To further guard 
against undue influence, if someone calls on a woman‟s behalf, 
perhaps inquiring about how much she can make for providing 
her eggs, information about that person and the nature of the 
inquiry should be recorded and given to the patient advocate.  
Together with the initial provision of the pamphlet, these three 
sessions will provide a woman contemplating supplying her 
eggs with comprehensive information and sufficient time to 
consider that information, guarding against the making of a 
rash decision based on incomplete information (potentially a 
proxy of undue influence) to provide her eggs when confronted 
with the possibility of earning thousands of dollars. 
All of these interactions, from the initial phone call 
through the in-person meetings and the egg extraction, should 
occur with people and entities unaffiliated with the researchers 
who will use the supplied eggs: researchers who need eggs to 
conduct their research unintentionally might downplay the 
risks of egg extraction.95  Likewise, to prevent situations akin 
to the scandal in South Korea, situations in which a woman 
may feel pressured (and thereby may be exploited) by a familial 
or employment relationship into providing her eggs, a woman 
who has a relationship with the researchers who will use her 
eggs or the doctors who will extract her eggs should be 
prohibited from undergoing egg extraction.96  To insulate the 
patient advocates‟ interaction with women, thereby allowing 
women to talk freely with them, the patient advocates should 
be unaffiliated with the doctors and counselors attending the 
women. 
Additionally, the Board should allocate a portion of its 
funds to conducting research about the demographic and 
 
94. See supra note 51 and accompanying text.  In this regard, a patient 
advocate may uncover domestic violence, especially considering that domestic 
violence increases in times of financial strain and that financial strain may 
cause a husband to demand that his wife supply her eggs in order to relieve 
that strain.  See, e.g., Peter C. Alexander, “Herstory” Repeats: The Bankruptcy 
Code Harms Women and Children, 13 AM. BANKR. INST. L. REV. 571, 579-80 
(noting the link between financial difficulties and domestic violence).  
Accordingly, patient advocates should have adequate knowledge to direct 
women to domestic violence support services. 
95. See Ikemoto, supra note 17, at 775 (discussing standards created by 
the California Institute for Regenerative Medicine, which impose similar 
requirements). 
96. See Gruen, supra note 21, at 304 (suggesting similar safeguards). 
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socioeconomic composition of the women it compensates to 
provide their eggs.  Such research will generate needed 
information about the backgrounds of women who supply their 
eggs for stem cell research.  This information can be used, 
perhaps by the “institutional oversight committee,” to tailor the 
“dynamic process” of informed consent to the needs and 
educational level of the women interacting with it, thereby 
ensuring that the women contemplating supplying their eggs 
make fully informed decisions.97 
Further, if at any time during egg production the woman 
wants to stop the procedure, she should be allowed to do so 
without repercussions: she should be paid proportionally for 
the part of the procedure she fulfilled, and she should be 
offered all the continuing medical and other care women who 
complete egg extraction are given.  Considering the potential 
for long-term risks arising from egg extraction, after the 
extraction, the woman should be offered continuing no-cost 
medical care for both physical and psychological needs caused 
by undergoing the procedure, including suggested follow-ups to 
assess her ongoing condition and to gather data for research 
about the effects of egg production and extraction.98  
Individuals and entities affiliated with this care should be 
unassociated with the researchers who intend to use the 
supplied eggs and with the doctors who extracted the eggs, 
both groups of whom may have a stake in ensuring that women 
do not report severe (or any) problems with egg production and 
extraction. 
To reduce the potential health risks of egg extraction, the 
number of times a woman may undergo egg extraction should 
be limited to at most six, and women at higher risk for 
developing OHSS should be prohibited from providing their 
eggs or should be allowed only to supply their eggs if they do 
not undergo ovarian hyper-stimulation.99  Indeed, in light of 
 
97. If the Board is concerned about creating a caste system under which 
certain women provide eggs for stem cell research while certain other women 
provide eggs for reproductive purposes, the Board can use this information to 
ensure that those women, on average, who provide eggs for reproductive 
purposes are also supplying their eggs for stem cell research. 
98. See Ikemoto, supra note 17, at 775 (discussing standards created by 
the California Institute for Regenerative Medicine, which stipulate that no-
cost continuing medical care must be provided). 
99. See ADAM BALEN, OVARIAN HYPERSTIMULATION SYNDROME (OHSS): A 
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the dearth of research about the short and long-term effects of 
ovarian hyper-stimulation, if the Board is serious about 
protecting the women it entices to provide their eggs, the Board 
should implement a rule that no eggs may be harvested from 
women using ovarian hyper-stimulation.  Such a rule 
necessarily will decrease the number of eggs extracted from 
each woman, but also will decrease the compensation amount 
reasonably due to each woman and may increase the number of 
women willing to provide their eggs.  These effects considered 
together, the Board may be able to purchase a similar amount 
of eggs for a similar amount of money while drastically 
decreasing the potential risk to women by mandating that 
women be “naturally cycled” when they provide their eggs.  
Overall, though some of these safeguards may seem excessively 
burdensome and restrictive, considering the many risks of—
and dearth of research concerning—the egg extraction 
procedure, the lack of direct benefit beyond payment to women 
supplying their eggs, and that these women do not need to 
undergo egg extraction but to advance stem cell research, these 
safeguards should be viewed as appropriate and sound, at least 
until more is known about the risks of egg extraction. 
Finally, returning to the need for research, the Board 
should allocate a portion of its funds to conducting studies of 
the short and long-term effects (both physical and 
psychological) of egg production and extraction.100  If the Board 
is prepared to advertise its compensation program to tens 
(perhaps hundreds) of thousands of women and to extract 
hundreds upon hundreds of eggs from them, as will be needed 
for stem cell research, then the Board should be willing to 
spend money to determine how the procedure is affecting the 
women it is paying. 
 
 
SHORT REPORT FOR THE HFEA 14 (2008) (Eng.), available at 
www.hfea.gov.uk/docs/OHSS_UPDATED_Report_from_Adam_Balen_2008.pd
f (detailing the risk factors for OHSS, suggesting to “limit[ ] the number of 
stimulated cycles for a given oocyte donor to approximately six,” and 
generally discussing the risks of OHSS).  See also supra note 32. 
100. See Spar, supra note 3, at 1290 (detailing what these studies should 
entail). 
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IV. Conclusion 
 
Taking the payment of women who provide eggs for 
reproductive purposes and the allowance of altruistic donation 
for research as given, the Board, acting on behalf of the State of 
New York, has decided to compensate women for providing 
their eggs for stem cell research.  As the first state to allow 
payment to women in this context, it is critical that the Board 
adequately and effectively monitor the consequences of its 
program.  In addition to clarifying the safeguards it has 
outlined in its written opinion, the Board should bolster its 
decision by adding requirements that take into account the 
possible differences between women who provide their eggs for 
reproductive purposes and women who provide their eggs for 
stem cell research, and that address the potential continuing 
needs of all women who provide their eggs.  Particularly, 
adding income or wealth requirements, and allocating a portion 
of its funds to conducting research about the demographic and 
socioeconomic composition of the women it compensates, and 
physiological and psychological effects of the egg extraction 
procedure on those women, will facilitate what should be New 
York‟s primary goals as to how women interact with its 
payment program: to identify and reduce the percentage of 
women unduly induced or exploited into providing their eggs, 
thereby allowing women to exercise the fullest possible control 
over their bodies, and to ensure that those women who do 
freely provide their eggs are able to do so with the greatest 
possible knowledge of the risks of egg production and 
extraction. 
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